BioNTech SE
Long

$BNTX PT 300 and higher

784
PFE and BNTX Partnership
Pfizer Is Ready, Even For COVID-19 Variants
This week is all about healthcare with Pfizer Inc. (NYSE: PFE), Sanofi SA (NASDAQ: SNY), Regeneron Pharmaceticals Inc (NASDAQ: REGN), and Bristol-Myers Squibb Co (NYSE: BMY) reporting earnings. But, what is under the spotlight is the effort pharmaceutical and biotech companies are making to combat COVID-19 or more precisely, the vaccine. Pfizer was the first who brought it to the market and gained FDA approval along with using the ground-breaking mRNA technology successfully.
Pfizer's Scientific Success

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.